FilingReader Intelligence

Star Lake Bioscience releases 146m restricted shares

July 23, 2025 at 11:01 AM UTC•By FilingReader AI

Star Lake Bioscience will release 146,395,365 restricted shares from its 2022 asset acquisition and fundraising for public trading on July 29, 2025.

The shares, held by Yipin Group and Tie Xiaorong, represent 8.81% of total share capital after completing their 12-month lock-up period and performance commitments.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Citic Securities Co., Ltd.'s verification opinion on the lifting of restrictions on restricted shares and their listing and circulation regarding Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd.'s issuance of shares and payment of cash to acquire assets and raise supporting funds, as well as the related-party transaction.July 23, 2025 at 08:00 AM UTC

Supplementary Source Documents

Announcement on the listing of certain restricted shares in connection with the issuance of shares and payment of cash for asset acquisition, coupled with the raising of supporting funds, constituting a connected transactionJuly 23, 2025 at 08:00 AM UTC

Star Lake Bioscience Inc Zhaoqing Guangdong

SSE:600866•Shanghai Stock Exchange

RSS feed for Star Lake Bioscience Inc Zhaoqing Guangdong

News Alerts

Get instant email alerts when Star Lake Bioscience Inc Zhaoqing Guangdong publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →